In this podcast, authors Julie Silverstein, MD, and Alexandra Martirossian, MD, discuss the physiology of growth hormone deficiency and differences between childhood- and adult-onset growth hormone deficiency. This is part 2 of their podcast series on their recent Consultant review article, "Diagnosis and Management of Growth Hormone Deficiency in Adults." More at www.consultant360.com

In this podcast, authors Julie Silverstein, MD, and Alexandra Martirossian, MD, discuss their recent Consultant review article, "Diagnosis and Management of Growth Hormone Deficiency in Adults." This is part 1 of a 3-part series. More at www.consultant360.com

In this podcast, Sumita Khatri, MD, MS, and Teal Hallstrand, MD, MPH, speak about a new clinical practice guideline on fractional exhaled nitric oxide (FeNO) to help guide asthma treatment, including detailed explanations of the studies the expert panel evaluated and considered when making this recommendation.

In this podcast, Jesse Roman, MD, provides an overview of new resources for clinicians on managing progressive fibrosing interstitial lung disease and connective tissue-related interstitial lung disease, including clinical presentation, prevalence, potential risk factors, genetic factors, and diagnosis, and management.

In this podcast, Brian G. DeRubertis, MD, answers our questions about his session at the 2021 VEITHsymposium, which highlighted 2 large clinical trials on the more-aggressive strategies of thrombus removal for patients with deep vein thrombosis. More at: www.consultant360.com

In this podcast, Peter Henke, MD, talks about his recent session at the 2021 VEITHsymposium, during which he talked about the research supporting newer direct oral anticoagulation (DOAC) therapies, the future of research, and which patients should receive DOACs after lower extremity bypass surgery.

William Schaffner, MD, on Vaccination Recommendations and Strategies for Implementation by Consultant360

In this podcast, Saad Z. Usmani, MD, MBA, speaks about the efficacy of daratumumab, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma and impaired renal function from the phase 3 Maia Study based on Lenalidomide starting dose. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.

In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.

In this podcast, Rohan Henry, MD, MS, speaks about childhood growth hormone deficiency, including how the diagnostic criteria have evolved over time and the ethical implications of diagnosis.